Cargando…
An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
Background: Lung adenocarcinoma (LUAD) is a sex-biased and easily metastatic malignant disease. A signature based on 5 long non-coding RNAs (lncRNAs) has been established to promote the overall survival (OS) prediction effect on LUAD. Methods: The RNA expression profiles of LUAD patients were obtain...
Autores principales: | Liang, Jiali, Jin, Weifeng, Xu, Huaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748423/ https://www.ncbi.nlm.nih.gov/pubmed/36531243 http://dx.doi.org/10.3389/fgene.2022.1052092 |
Ejemplares similares
-
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021) -
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022) -
Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021) -
Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)